VOLUME 11, ISSUE 3- Summer 2017
World Views in Examining Drug Policy

go to this issue

Alternative Development and Counter-Narcotics Policies: Afghanistan, Lao PDR, and Myanmar

M. Reza Amirkhizi, PhD

Health Policy for Marijuana

Norman S Miller, MD, JD, and Thersilla Oberbarnscheidt, MD, PhD

VOLUME 11, ISSUE 2- Spring 2017
World Perspectives on Substance Abuse Policy

go to this issue

Prevalence and Correlates of Alcohol Consumption During Pregnancy in Georgia: Evidence from a National Survey

Manouchehr Mokhtari, Ph.D.; Anthony Kondracki, MD, MPH; Lasha Kavtaradze, Ph.D.; Jacqueline Wallen, MSW, Ph.D.; Mamak Ashtari, MBA; Gvantsa Piralishvili, MD, Ph.D.; Marina Topuridze, MD; Khatuna Todadze, MD; Lasha Kiladze, MD; Nino Gachechiladze, MS

Social Determinants and Substance Use: A Perspective Beyond the Policy ‘Silo’ Pragmatics

Shane Varcoe, National Training & Partnerships Officer, Dalgarno Institute, and Derek Steenholdt, Research Officer, Dalgarno Institute

VOLUME 11, ISSUE 1- Winter 2017
Developing Substance Abuse Policy: Perspectives from Around the World

go to this issue

Are Prescription Opioids Creating a New Type of Heroin User?

Robert L. DuPont, MD (corresponding author), Katherine Garcia-Rosales, BS, Corinne L. Shea, MA, Helen DuPont, MBA, Michael D. Campbell, PhD, George Kolodner, MD, Eric D. Wish, PhD

An Analysis of the Data on the Effectiveness of Policies in Controlling Production of Illicit Narcotics in Afghanistan

M. Reza Amirkhizi, Ph.D.

VOLUME 10, ISSUE 3- Fall 2016
Developing Substance Abuse Policy: Perspectives from Around the World

go to this issue

Why a 5 ng/ml THC Limit is Bad Public Policy - and the Case for Tandem per se DUID Legislation

Ed Wood

Binge Drinking in the Oldest Wine Country: Evidence from the Noncommunicable Disease Risk Factor Surveillance

Manouchehr Mokhtari, Anthony Kondracki, Jacqueline Wallen, Lasha Kavtaradze, Mamak Ashtari, Marina Topuridze, Lela Sturua, Gvantsa Piralishvili, Khatuna Todadze, Lasha Kiladze, and Nino Gachechiladze

VOLUME 10, ISSUE 2- Summer 2016
Societal Trends in Drug Use and Policy

go to this issue

The Hidden Costs of Marijuana Use in Colorado: One Emergency Department's Experience

Ed Wood, Ashley Brooks-Russell, and Phillip Drum

VOLUME 10, ISSUE 1- Spring 2016
Science Gone Bad: From Research Labs to Clandestine Labs

go to this issue

Delays in DUI Blood Testing: Impact on Cannabis DUI Assessments

Ed Wood, Ashley Brooks-Russell, and Phillip Drum

Colorado’s Decriminalization of Marijuana: A Forecast for Justice System Administrators

Jon E. Lopey, Sr., University of Nevada, Reno

VOLUME 9, ISSUE 4- Winter 2015
Science Gone Bad: From Research Labs to Clandestine Labs

go to this issue

Synthetic Drugs: A “Viral’ Outbreak

Sharon S. Kelley, MS, PhD

VOLUME 9, ISSUE 3- Fall 2015
Assessing the Impacts of Marijuana in America

go to this issue

Assessing Physicians’ Perspectives and Knowledge of Medical Marijuana and the Delaware Medical Marijuana Act

Barret Michalec, PhD; Laura Rapp, PhD; Tanya Whittle, MA
Center for Drug & Health Studies, University of Delaware

Medicinal and Recreational Marijuana: What are the Risks?

Shawn Van Gerpen, MD; Tamara Vik, MD; Timothy J. Soundy, MD

20 Flaws in Study Finding No Health Problems in Adult Males Who Were Chronic Marijuana Users as Teens, Young Adults

Dr. Bertha K. Madras

VOLUME 9, ISSUE 2- Summer 2015
The Impact of Substance Abuse on Society

go to this issue

What Will Legal Marijuana Cost Employers?

Sue Rusche and Dr. Kevin Sabet

VOLUME 9, ISSUE 1- Spring 2015
Bridging the Gap: The Role of Science in Policy Part II

go to this issue

Selling Prevention: Using a Business Framework to Analyze the State of Prevention and Overcome Obstacles to Expanding Substance Abuse Prevention

Theodore L. Caputi

VOLUME 8, ISSUE 4 - Winter 2014
Bridging the Gap: The Role of Science in Policy

go to this issue


State Laws Legalizing Marijuana Do Not Make Marijuana Legal Under Federal Law

David G. Evans, Esq.

VOLUME 8, ISSUE 3 - Fall 2014
The Global Climate of Drug Abuse Part 2

go to this issue


HIV and HCV Transmission Among Intravenous Drug Users

Dr Ross Colquhoun, Dalgarno Institute, Gary Christian, Drug Free Australia

Changing Market Culture for Methamphetamines

Josephine Baxter, Executive Officer, Drug Free Australia

VOLUME 8, ISSUE 2 - Summer 2014
The Global Climate of Drug Abuse

go to this issue


Why do people use medical marijuana? The medical conditions of users in seven U.S. states

Kevin A. Sabet, Ph.D., Elyse Grossman, J.D., M.P.P.

Marijuana Poisoning Republished with permission from the author Kevin T. Fitzgerald, PhD

Kevin T. Fitzgerald, PhD, DVM, DABVPa•*, Alvin C. Bronstein, MD, FACEPb, Kristin L. Newquist, BS, AAS, CVTa

VOLUME 8, ISSUE 1 - Spring 2014
Global Substance Abuse Trends: Connecting the Science and the Policy

go to this issue


Marijuana Usage In Chronic Pain Patients: Driving and Work Guidelines for Clinicians

Gerald M. Aronoff, MD, DABPM, Past President American Academy of Pain Medicine Carolina Pain Associates, PA, Charlotte, North Carolina

Characteristics and Evidences of Effectiveness of a Locally Developed Prevention Framework: The Community Prevention Education Continuum

Colin Mangham, Drug Prevention Network of Canada

VOLUME 7, ISSUE 4 - Winter 2013
The Impact of Drug Policies on our World

go to this issue


The Economic Impacts of Marijuana Legalization

David G. Evans, Esq., Executive Director, Drug Free Projects Coalition

School-Based Substance Abuse Prevention: An Initial Review of The Red Ribbon Certified Schools Program

Steven G. Brooks, Florida State University

Jamie M. Clem, Florida State University Florida State University Center for Prevention Research 3200 Commonwealth Blvd, Tallahassee, FL, 32303

Corresponding author: Steven G. Brooks (850) 644-3016

VOLUME 7, ISSUE 3 - Fall 2013
Substance Abuse in Our World: Then, Now and Future - Part II

go to this issue


Rapid Methadone Detoxification using Morphine to Reduce Severity of Withdrawal

IDr Ross Colquhoun, D H Sc, M App Sc (Neuroscience), B Sc Hons (Psych), Grad Dip Counselling and Psychotherapy Research Fellow for Drug Free Australia ( Coordinator of the Sydney office of the Dalgarno Institute, Australia

VOLUME 7, ISSUE 2 - Summer 2013
Substance Abuse in Our World: Then, Now and Future

go to this issue



Drugs in Africa 2013

Ian Oliver

Drug Testing in South America and the Potential New Crack Epidemic- “Crack Plus”

Patricio Labatut, David Martin, PhD and John Mazur

VOLUME 7, ISSUE 1 - Spring 2013

go to this issue


The Use of Cannabis for Medical Purposes

Josephine H. Baxter, Herschel M. Baker, A. Stuart Reece MD

VOLUME 6, ISSUE 4 - Winter 2012

go to this issue


The Interrelationship Between Sexuality and Drug Abuse: Sexual health as an important component in women’s recovery from trauma and substance abuse
Germayne B. Tizzano, Ph.D., President and Founder Views From a Tree House, Inc.

VOLUME 6, ISSUE 3 - Fall 2012

go to this issue



An Updated Review of the Research on the Risks and Harms Associated to the Use of Marijuana
Jordan Diplock, Dr. Darryl Plecas and Len Garis; Centre for Public Safety and Criminal
Justice Research, School of Criminology and Criminal Justice, University College of the Fraser Valley

Designer Drugs: An Escalating Public Health Challenge
Bertha K. Madras, PhD

VOLUME 6, ISSUE 2 - Summer 2012

go to this issue



The Use of Methadone or Naltrexone for Treatment of Opiate Dependence: An Ethical Approach
Dr Ross Colquhoun, Doctor Health Science, Master Applied Science (Neuroscience), Bachelor Science Honors (Psych), Graduate Diploma Counselling and Psychotherapy Clinical Director, Addiction Treatment and Psychology Services, Australia

VOLUME 6, ISSUE 1 - Spring 2012
go to this issue


Perceptions and Use of Medical Marijuana in an Urban Substance Treatment Program
Corresponding Author: Charles Shuman M.D.
Rationale for Using Exercise in the Treatment of Stimulant Use Disorders
Tracy L. Greer, Ph.D. a; Kolette M. Ring, B.A. a; Diane Warden, Ph.D., M.B.A. a, Bruce D. Grannemann, M.A. a; Timothy S. Church, M.D., Ph.D., M.P.H. b; Eugene Somoza, M.D., Ph.D. c; Steven N. Blair P.E.D d, e; Jose Szapocznik, Ph.D.f; Mark Stoutenberg, Ph.D.f; Chad Rethorst, Ph.D. a; Robrina Walker, Ph.D.a; David W. Morris, Ph.D. a; Andrzej S. Kosinski, Ph.D. g; Tiffany Kyle, Ph.D. h; Bess Marcus, Ph.D.i; Becca Crowell, M.Ed., Ed.S. j; Neal Oden Ph.D.k; Edward Nunes, M.D. l ; Madhukar H. Trivedi, M.D. a; a The University of Texas Southwestern Medical Center at Dallas b Preventive Medicine Laboratory, Pennington Biomedical Research Center c Cincinnati Addictions Research Center (CinARC); Department of Psychiatry, University of Cincinnati College of Medicine d Department of Exercise Science, University of South Carolina e Department of Epidemiology and Biostatistics, University of South Carolina f Department of Epidemiology and Public Health, University of Miami, Miller School of Medicine, g Department of Biostatistics and Bioinformatics, Duke University Medical Center, Duke Clinical Research Institute h The Center for Drug-Free Living i Department of Family and Preventive Medicine, The University of California, San Diego j Nexus Recovery Center, Inc k The EMMES Corporation l New York State Psychiatric Institute/Department of Psychiatry, College of Physicians and Surgeons of Columbia University

VOLUME 5, ISSUE 4 - Winter 2011
Evolution of Drug Policy, Part II

go to this issue



Employee Drug Testing: Study Shows Improved Productivity and Attendance and Decreased Workers’ Compensation and Turnover
PNeil A. Fortner, MS, FTS-ABFT, TC-NRCC, David M. Martin, PhD, S. Evren Esen and Laura Shelton
To Schedule or Not to Schedule: How Well Do We Decide?
Jonathan P. Caulkins, Ph.D. and Carolyn Coulson, MSPPM
The Role of the Physician in “Medical" Marijuana
President’s Action Committee on Medical Marijuana of the American Society of Addiction Medicine
Mingling Activism with Policy Influence: Harm Reduction Ideology and the Politicisation of Canadian Drug Policy
Colin R. Mangham, PhD

VOLUME 5, ISSUE 3 - Fall 2011
Evolution of Drug Policy

go to this issue



The Swedish Drug Policy Experience: Past to Present
Per Johansson, Secretary General National Association for a Drug-Free Society (RNS)
Going Dutch: drug policy developments in the Netherlands
Frans S.L. Koopmans De Hoop Foundation, Dordrecht, The Netherlands

VOLUME 5, ISSUE 2 - Summer 2011
A Decade of Marijuana

go to this issue



Mile High Macaroons: The Medicalization of Marijuana in Colorado
Abraham M. Nussbaum, MD, MTS, Christian Thurstone, MD
Medical Marijuana, Nevada's Big Gamble
Todd Raybuck
The Impact of Oregon's Marijuana Program
Shirley Morgan

VOLUME 5, ISSUE 1 - Spring 2011
International Controversies in Drug Treatment

go to this issue


The UK's Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes
Kathy Gyngell
The Sydney Injecting Centre - Assessing The Evidence-Base
Gary Christian
Chronic Pain Management Using Buprenorphine: Questions and Considerations
Mel Pohl, M.D, FASAM, Medical Director, Las Vegas Recovery Center, Logan Smith, B.A, Program Development Coordinator, Las Vegas Recovery Center

VOLUME 4, ISSUES 3 - Fall 2010
Substance Abuse and the Role ofthe Court System: Problems and Policy
Solutions from Prenatal Exposure to Adulthood

go to this issue


Recreational, Reactive, and Really Bad Crimes: Uncovering the Role of Sex and Drugs in Juvenile Court
Judge Irene Sullivan
Drug Courts A Viable Solution to Drug Dependent Offenders
West Huddleston
HOPE for Probation: How Hawaii Improved Behavior with High-Probability, Low-Severity Sanctions
Angela Hawken, Ph.D., Associate Professor of Economics and Policy Analysis, School of Public Policy, Pepperdine University
A Multi-national Pre-consensus Survey: The Principles of Treatment of Substance Use Disorders during Pregnancy
Hendree E. Jones, Lucy Burns, Laurent Gourarier, Einat Peles, Marianne Springer-Kremser, and Gabriele Fischer

VOLUME 4, ISSUES 1 and 2 - Spring/Summer 2010
Current Issues Surrounding Marijuana: The Science, the Law, the Victims

go to this issue


Early Findings in Controlled Studies of Herbal Cannabis: A Review
Andrea G. Barthwell, MD, FASAM
Pawns of Pot: The Coexistence of Marijuana and Animal Crimes
Dr. Kris Otteman DVM, Director of Shelter Medicine, Oregon Humane Society and Emily Davidsohn, Oregon Humane Society
Medical Marijuana Laws: Obstructing Congress?
Paula A. Barran, A.B. M.A., Ph.D., J.D., MBA

VOLUME 3, ISSUE 4 - Winter 2010
go to this issue

An Overview of Present and Future Drug Testing
David M. Martin, Ph.D.
Drug Testing in Clinical Settings
Robert L. DuPont, M.D.
President, Institute for Behavior and Health

Drug Testing of Students
David Evans, J.D.
Drug Testing In The Workplace: An historical and economic examination
Calvina Fay

go to this issue

Alcohol Promotion on Facebook
Sarah Mart, Jacob Mergendoller, Michele Simon
Marin Institute, San Rafael, California, United States

Adolescent Brain Development and Alcohol Abuse
Ken C. Winters, Ph.D.
Professor, Department of Psychiatry, University of Minnesota
Senior Scientist, Treatment Research Institute

Reducing Youth Access ? The Impact of Policy Change
Michelle Voth, Executive Director, Kansas Family Partnership

go to this issue

Jordan Diplock, Irwin Cohen, and Darryl Plecas School of Criminology and Criminal Justice, University College of the Fraser Valley, Abbotsford, British Columbia, Canada

go to this issue

A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., Vera R. Leopold, B.A., Jana L. Wichelecki, B.A.
A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 2
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., Vera R. Leopold, B.A., Jana L. Wichelecki, B.A.
Barack Obama on Medical Marijuana
Robert L. DuPont, M.D.

go to this issue

What I Wish From Our New Administration

David A. Gross, MD, DFAPA
Cutting The Gordian Knot of Drug Addiction Confusion

Dr Stuart Reece, General Practitioner in Brisbane, Australia
Is the Glass Half Empty, Half Full or Dry?
Tavis Glassman, PhD, MPH, CHES
Afghanistan: An Enduring Problem
Ian Oliver

Coordinating Patient Care and Predicting Alcohol Consumption: Expectations and Behavior

go to this issue

Addiction in Clinical Practice: Psychiatry
William M. Greene, MD; Mark E. Sylvester, MD; Lisa J. Merlo, PhD
Substance Abusing Patients in the Primary Care Setting: They Deserve Treatment Too
Kendall M. Campbell, MD
Emergency Medicine and Addiction Medicine: Much in Common
Daniel P. Logan, M.D., F.A.C.E.P.
Using the Theory of Planned Behavior to Predict Alcohol Consumption among College Students on Game Day
Tavis Glassman PhD, MPH, CHES, Virginia Dodd, PhD, MPH, Jiunn-Jye Sheu, PhD, MSPH, CHES, Barbara A. Rienzo, PhD, Alexander C. Wagenaar, PhD

Current Issues in Drug Abuse and Treatment: Implications for Identifying Risk

go to this issue

Patterns and Characteristics of Prescription Opioid Abuse in the United States
Theodore J. Cicero, PhD1, Michael Lynskey, PhD1, Alexandre Todorov, PhD1, James Inciardi, PhD2, Hilary Surratt, PhD2
Neurobiology of Addiction and the Adolescent Brain
Deborah R. Simkin, M.D., Section Head, Division of Child and Adolescent Psychiatry, Residency Director Department of Psychiatry, University of South Alabama College of Medicine
Physicians Impaired by Substance Abuse Disorders
Kimberly B. Gold, MS4, Yale University School of Medicine, Scott A. Teitelbaum, M.D., F.A.A.P., A.S.A.M., Associate Professor, University of Florida School of Medicinen
The Use of Intervention and Case Management Models in Maximizing Recovery and Reducing Relapse Risks for Substance Abusers
Kate Caravella, CAC, NCAC 1, BRI 1

Prescribing Controlled Substances: A Physician's Dilemma, a Patient's Responsibility and the Public's Protection

go to this issue

Prescribing Controlled Substances Reconsidered
Eric A. Voth, M.D., FACP, Chairman, The Institute on Global Drug Policy
Thawing the Chill: The U.S. Drug Enforcement Administration, Physicians and the Controlled Substances Act
Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, DEA
Addiction Treatment: A Psychiatrist's Perspective
David A. Gross, MD, Distinguished Fellow of the American Psychiatric Association
Interventional Pain Procedures: Understanding their Role in Clinical Practice
Ian J. Kucera, M.D., Pharm.D., Director of Pain Medicine Stormont-Vail Healthcare, Topeka, KS

Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue

Harm Reduction the Idea and the Ideology
Professor Dr A. Hamid Ghodse, Member and Past President, INCB.
When Harm minimization is not harm minimization Australia as a Case Study
Stuart Reece MBBS (Hons), FRCS (Ed.), FRCS (Glas.), MD, FRACGP
The Local Matters: A Brief History of the Tension Between Federal Drug Laws and State and Local Policy
Kevin A. Sabet, Ph.D.
Putting ethics in its place right at the heart of drug policy debates
Dr Gregory K Pike, PhD
History of Harm Reduction - Provenance and Politics, Part 3
Peter Stoker C. Eng. ? Director, National Drug Prevention Alliance, UK

Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy

go to this issue

The Effectiveness of Needle Exchange Programmes for HIV Prevention - A Critical Review
Kerstin Käll, Ulric Hermansson, Ellen J. Amundsen, Klas Rönnbäck and Sten Rönnberg
A Critical Evaluation of the Effects of Safe Injection Facilities
Garth Davies
The Public Health Dangers of Drug Abuse in Prisons
Ian Oliver
History of Harm Reduction - Provenance and Politics, Part 2
Peter Stoker C. Eng.

Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy

go to this issue

The Lure and the Loss of Harm Reduction in UK Drug Policy and Practice
Neil McKeganey, BA, MSc, PhD, FRSA
A Critique of Canada's INSITE Injection Site and its Parent Philosophy: Implications and Recommendations for Policy Planning
Colin Mangham, PhD
Is It Harm Reduction - Or Harm Continuation?
Peter O'Loughlin
History of Harm Reduction Provenance and Politics, Part 1
Peter Stoker C. Eng.

Marijuana: The present challenge and the future of cannabinoid research

go to this issue

Marijuana and cannabinoid research: Current status and future potential
Eric A. Voth, MD, FACP
From Mockery to Medicine: The Story of the Development of a Serious Modern Medicine
Andrea G. Barthwell, MD, FASAM
Marijuana and Adolescents
Edward A. Jacobs, MD, FAAP

Advertise With Us


RSS Privacy Policy Terms of Use Contact Us Information for Authors